Pediatric Autoimmune Liver Disease
Henry C. Lin – 22 May 2022
Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease
- Read more about Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease
Rachel L. Bachrach, Shari S. Rogal – 22 May 2022
Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease
Rachel Holmes, Anahli Patel, Archita P. Desai – 22 May 2022
Treatment of Mental Health in Patients With Chronic Liver Disease
Thomas G. Cotter, Thomas Beresford – 22 May 2022
Clinical Phenotyping and the Application of Precision Medicine in MAFLD
Saad Saffo, Albert Do – 22 May 2022
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: A systematic review
Ivo J. Schurink, Fenna E. M. Leemkolk, Constantino Fondevila, Riccardo De Carlis, Eric Savier, Gabriel C. Oniscu, Volkert A. L. Huurman, Jeroen Jonge – 22 May 2022 – Acceptance of liver grafts from donations after circulatory death (DCD) largely remains a “black box,” particularly due to the unpredictability of the agonal phase. Abdominal normothermic regional perfusion (aNRP) can reverse ischemic injury early during the procurement procedure, and it simultaneously enables graft viability testing to unravel this black box.
Pediatric Autoimmune Liver Disease
Henry C. Lin – 22 May 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference
Andrew M. Shearer, Yanling Wang, Elizabeth K. Fletcher, Rajashree Rana, Emily S. Michael, Nga Nguyen, Manal F. Abdelmalek, Lidija Covic, Athan Kuliopulos – 22 May 2022
Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease
- Read more about Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease
Rachel L. Bachrach, Shari S. Rogal – 22 May 2022
Letter to the editor: Atezolizumab plus bevacizumab for hepatocellular carcinoma in the real world
Junwei Zhang, Jinyu Fang, Ziyu Xun, Yiyao Xu, Xin Lu, Haitao Zhao – 22 May 2022